China's 'open-source' modernization offers inspiration for global development, says expert
BEIJING, March 20, 2026 /PRNewswire/ -- A report from People's Daily: China's recently approved outline of the 15th Five-Year Plan (2026-2030) has drawn significant global attention, not just for its economic targets, but for the unique nature of...
Hong Kong Startup Comfiknit Shares Breakthrough Technology at the MIT Sports Summit
Subverting the Concept of "Fast-Drying" and Redefining Sports Functional Clothing HONG KONG, March 20, 2026 /PRNewswire/ -- Eczewear's parent company, Comfiknit, a Hong Kong SAR-based health tech company developing sweat-management functional...
MGI Tech and NUS Pharmacy and Pharmaceutical Sciences Announce Collaboration on DCS Lab to Accelerate Multi-Omics Innovation in Pharmaceutical Sciences
SINGAPORE, March 20, 2026 /PRNewswire/ -- MGI Tech Singapore Pte. Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and the Department of Pharmacy and Pharmaceutical Sciences in the...
Matrixport Rebrands as BIT in Strategic Repositioning
Publishes Trust Whitepaper outlining governance and operational frameworks as institutional participation in digital asset markets grows. SINGAPORE, March 20, 2026 /PRNewswire/ -- Matrixport announced that it has rebranded as BIT, reflecting the...
From Volcanoes to No-Man's Land, Infinix NOTE 60 SERIES Is Built for Every Extreme
Across a cinematic journey through Earth's extremes, the Infinix NOTE 60 SERIES proves itself as essential gear, built to capture every moment while keeping users seamlessly connected to the world. HONG KONG, March 20, 2026 /PRNewswire/ -- As...
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016
SUZHOU, China, March 20, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispecific antibody-drug...
HEROAD Unleashes a New Era of Gaming: Professional-Grade Gear Meets Unbeatable Value
SHENZHEN, China, March 20, 2026 /PRNewswire/ -- QCY is proud to announce the official launch of HEROAD, a disruptive new e-sports brand dedicated to redefining the competitive landscape. Built on the core philosophy of "For Gamers. For Winners,"...
HOY Unveils a Powerhouse Line-up of Talent for its Bold New Chapter
Exclusive Asian Games Broadcast for Eight Consecutive Years Launching Brand-New KOL Variety Show "I Want to Be a YouTuber" and "I Want to Be an Anchor" Partnering with International Records Labels to Create Groundbreaking Entertainment Experiences...